Study: Long-Term CB2R Activation “Might Prevent Neuroinflammation and Oxidative Stress-Associated Sickness Behavior”

Activation of the cannabinoid receptor 2 (CB2R), something done naturally through the consumption of cannabis and cannabinoids, “might prevent neuroinflammation and oxidative stress-associated sickness behavior”, according to a new study.

The study, titled Cannabinoid receptor 2 activation mitigates lipopolysaccharide-induced neuroinflammation and sickness behavior in mice, is being published in the journal Psychopharmacology. It was epublished ahead of print by the U.S. National Institute of Health.

“Cannabinoid receptor 2 (CB2R) signaling in the brain is associated with the pathophysiology of depression”, states the study’s abstract. “Sickness behavior, characterized by lessened mobility, social interaction, and depressive behavior, is linked with neuroinflammation, oxidative stress, and immune system. The present study was aimed at evaluating 1-phenylisatin (PI), a CB2R agonist, in sickness behavior.”

Read moreStudy: Long-Term CB2R Activation “Might Prevent Neuroinflammation and Oxidative Stress-Associated Sickness Behavior”

Study: Cannabigerol May Treat Neuroinflammation and Oxidative Stress

According to a new study published by the International Journal of Molecular Sciences, the cannabis compound cannabigerol “may be a potential treatment against neuroinflammation and oxidative stress.”

“Inflammation and oxidative stress play main roles in neurodegeneration”, states the study’s abstract. “Interestingly, different natural compounds may be able to exert neuroprotective actions against inflammation and oxidative stress, protecting from neuronal cell loss. Among these natural sources, Cannabissativa represents a reservoir of compounds exerting beneficial properties, including cannabigerol (CBG), whose antioxidant properties have already been demonstrated in macrophages.”

With this in mind, researches “aimed to evaluate the ability of CBG to protect motor neurons against the toxicity induced from the medium of LPS-stimulated RAW 264.7 macrophages.”

Read moreStudy: Cannabigerol May Treat Neuroinflammation and Oxidative Stress

Cannabis May Treat Neuroinflammation, According to New Study

A study published in the Februaryneuro issue of the Journal of NeuroImmune Pharmacology has found that cannabis may provide a treatment option for neuroinflammation.

“Chronic neuroinflammatory disorders (such as HIV associated neurodegeneration) require treatment that decreases production of inflammatory factors by activated microglia and macrophages and protection of blood brain barrier (BBB) injury secondary to activation of brain endothelium”, begins the study’s abstract. “Cannabioid type 2 receptor (CB2) is highly expressed on macrophages and brain microvasular enndothelial cells (BMVEC) and is upregulated in inflammation and HIV infection. It has been shown that CB2 activation dampened inflammatory responses in macrophages and BMVEC.”

Read moreCannabis May Treat Neuroinflammation, According to New Study

Cannabinoids Can Treat Neuroinflammation, According to New Study

A new study published in the journal Cell Immunology has found that activation of the body’s cannabinoid receptorsneuro – something done naturally by cannabis and cannabinoids – has neuroinflammatory capabilities.

According to the study; “Here we showed that Gp1a, a highly selective CB2 [cannabinoid receptor 2] agonist, with a four log higher affinity for CB2 than CB1, reduced clinical scores and facilitated recovery in EAE [experimental autoimmune encephalomyelitis, a disease of the central nervous system] in conjunction with long term reduction in demyelination and axonal loss.”

Read moreCannabinoids Can Treat Neuroinflammation, According to New Study